On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...